—
Title: Trump Reverses Course, Urges Congress to Protect CBD Products From November Ban
Site: CBDWorldNews.com
Category: Regulation & Policy
Primary Keyword: Trump hemp ban Congress
Secondary Keywords: hemp product ban 2026, CBD regulation, full-spectrum CBD, November hemp deadline
Featured Image Search Term: US Capitol building legislation hemp
Unsplash Photo ID: 0hXWp8GyiG4
Photographer: terry bazemore iii
Unsplash Attribution: Photo by terry bazemore iii on Unsplash
Meta Description: Trump calls on Congress to fix the hemp ban he signed, urging protection for full-spectrum CBD products before the November 2026 deadline.
Tags: Trump, hemp ban, Congress, CBD regulation, federal policy
Word Count: 1050
Estimated Read Time: 5 minutes
Internal Links: CBDProducts.com full-spectrum CBD guide, SafeCBD.com lab testing standards
—
Affiliate Disclosure: This article contains affiliate links. We may earn a commission from qualifying purchases at no extra cost to you.
Trump Reverses Course, Urges Congress to Protect CBD Products From November Ban
The president who signed the restrictive hemp language now wants lawmakers to carve out protections for CBD consumers and farmers.
By CBDWorldNews Editorial Staff | April 28, 2026
—
Dek: President Trump’s April 23 statement marks a sharp reversal from the hemp restrictions he signed into law last November, creating new political pressure on Congress to act before the ban takes effect.
—
Seven months ago, President Trump signed a spending bill that redefined hemp and set the stage for what industry groups call the most disruptive regulatory change since the 2018 Farm Bill. Now he wants Congress to undo part of his own handiwork.
On April 23, Trump released a statement calling on lawmakers to “update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on.” The statement came just one day before the Washington Times reported that Trump’s shift amounted to a move “from signature to reversal.”
What the November Ban Actually Does
The spending bill Trump signed last November redefined hemp to restrict products containing more than 0.4 milligrams of total THC per container, more than 0.3% total THC including THCA, or any synthetic cannabinoids. The US Hemp Roundtable estimates that threshold would eliminate 95% of the products currently on shelves.
The restriction takes effect November 12, 2026. That gives Congress roughly six months to craft a legislative fix — or watch a $739 million industry lose most of its product catalog overnight.
A Collision With Medicare Coverage
The timing creates an unusual federal policy conflict. On April 1, Medicare began covering hemp-derived CBD products for eligible seniors through a pilot program, making the federal government both a buyer and a soon-to-be enforcer of a near-total product ban.
The Medicare pilot allows 3 milligrams of THC per serving. The November ban caps products at 0.4 milligrams per entire container — more than seven times lower, measured differently. Cornbread Hemp secured an exclusive contract with Alliant Purchasing, a group purchasing organization serving 68,000 healthcare locations, to supply USDA organic CBD products for the program.
> “We are simultaneously paying for CBD through Medicare and preparing to ban the products that qualify for coverage. That contradiction cannot stand.” — US Hemp Roundtable statement, April 2026
Congressional Solutions on the Table
Multiple bills are competing for attention as the Farm Bill moves through committee:
The American Hemp Protection Act (H.R. 6209), introduced by Rep. Nancy Mace (R-SC), would repeal the new federal hemp language entirely and revert to the 2018 Farm Bill definition.
The Hemp Safety Enforcement Act, introduced by Sens. Rand Paul, Amy Klobuchar, and Joni Ernst, would allow states to regulate hemp products according to their own frameworks rather than imposing a single federal standard.
Rep. James Comer’s amendment would delay the ban for one year, pushing the deadline to November 2027.
Rep. Andy Barr’s Legal Hemp Protection Act, circulated as a discussion draft on April 19, takes a different approach. It would create a full regulatory framework including testing requirements, packaging and labeling standards, age restrictions, retail licensing, and milligram caps determined by the FDA rather than Congress.
The Farm Bill Path
The House Agriculture Committee advanced the Farm, Food, and National Security Act of 2026 on March 5 with a 34-17 vote. Chairman Glenn Thompson (R-PA) ruled hemp product amendments non-germane, stating that regulating finished hemp products falls under the Energy and Commerce Committee and FDA, not Agriculture.
The Rules Committee took up the legislation on April 27. Whether hemp amendments can be attached during floor consideration remains the central question for the industry.
What Comes Next
Trump’s statement adds presidential weight to the push for a legislative fix, but it does not guarantee one. The president offered no specific proposal, leaving Congress to sort through competing approaches that range from full repeal to a regulated framework with federal oversight.
The industry faces a countdown. Manufacturers, retailers, and the 68 million Medicare beneficiaries who now have access to CBD coverage all operate under the same deadline: November 12.
For consumers navigating the current market, understanding [what makes a quality CBD product](https://cbdproducts.com/buying-guides) matters more than ever. Third-party [lab testing and certificates of analysis](https://safecbd.com/lab-testing-standards) remain the best tools for verifying product safety regardless of how the regulatory landscape shifts.
—
These statements have not been evaluated by the Food and Drug Administration. CBD products are not intended to diagnose, treat, cure, or prevent any disease.
